Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
Identifieur interne : 001F46 ( PubMed/Corpus ); précédent : 001F45; suivant : 001F47Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
Auteurs : Leandro F. Tarosso ; Mariana M. Sauer ; Sabri Sanabani ; Maria Teresa Giret ; Helena I. Tomiyama ; John Sidney ; Shari M. Piaskowski ; Ricardo S. Diaz ; Ester C. Sabino ; Alessandro Sette ; Jorge Kalil-Filho ; David I. Watkins ; Esper G. KallasSource :
- PloS one [ 1932-6203 ] ; 2010.
English descriptors
- KwdEn :
- CD4-Positive T-Lymphocytes, Cohort Studies, Epitopes (genetics), Epitopes (immunology), Genetic Variation (genetics), Genome, Viral (genetics), HIV Infections (immunology), HIV Infections (virology), HIV-1 (classification), HIV-1 (genetics), HIV-1 (immunology), HLA-B Antigens (genetics), Immunity, Cellular (genetics), Immunity, Cellular (immunology), Likelihood Functions, Phylogeny, Polymerase Chain Reaction, nef Gene Products, Human Immunodeficiency Virus (immunology), vif Gene Products, Human Immunodeficiency Virus (immunology).
- MESH :
- chemical , genetics : Epitopes, HLA-B Antigens.
- chemical , immunology : Epitopes, nef Gene Products, Human Immunodeficiency Virus, vif Gene Products, Human Immunodeficiency Virus.
- classification : HIV-1.
- genetics : Genetic Variation, Genome, Viral, HIV-1, Immunity, Cellular.
- immunology : HIV Infections, HIV-1, Immunity, Cellular.
- virology : HIV Infections.
- CD4-Positive T-Lymphocytes, Cohort Studies, Likelihood Functions, Phylogeny, Polymerase Chain Reaction.
Abstract
HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus.
DOI: 10.1371/journal.pone.0011436
PubMed: 20625436
Links to Exploration step
pubmed:20625436Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.</title><author><name sortKey="Tarosso, Leandro F" sort="Tarosso, Leandro F" uniqKey="Tarosso L" first="Leandro F" last="Tarosso">Leandro F. Tarosso</name><affiliation><nlm:affiliation>Clinical Immunology and Allergy Division, University of Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Sauer, Mariana M" sort="Sauer, Mariana M" uniqKey="Sauer M" first="Mariana M" last="Sauer">Mariana M. Sauer</name></author><author><name sortKey="Sanabani, Sabri" sort="Sanabani, Sabri" uniqKey="Sanabani S" first="Sabri" last="Sanabani">Sabri Sanabani</name></author><author><name sortKey="Giret, Maria Teresa" sort="Giret, Maria Teresa" uniqKey="Giret M" first="Maria Teresa" last="Giret">Maria Teresa Giret</name></author><author><name sortKey="Tomiyama, Helena I" sort="Tomiyama, Helena I" uniqKey="Tomiyama H" first="Helena I" last="Tomiyama">Helena I. Tomiyama</name></author><author><name sortKey="Sidney, John" sort="Sidney, John" uniqKey="Sidney J" first="John" last="Sidney">John Sidney</name></author><author><name sortKey="Piaskowski, Shari M" sort="Piaskowski, Shari M" uniqKey="Piaskowski S" first="Shari M" last="Piaskowski">Shari M. Piaskowski</name></author><author><name sortKey="Diaz, Ricardo S" sort="Diaz, Ricardo S" uniqKey="Diaz R" first="Ricardo S" last="Diaz">Ricardo S. Diaz</name></author><author><name sortKey="Sabino, Ester C" sort="Sabino, Ester C" uniqKey="Sabino E" first="Ester C" last="Sabino">Ester C. Sabino</name></author><author><name sortKey="Sette, Alessandro" sort="Sette, Alessandro" uniqKey="Sette A" first="Alessandro" last="Sette">Alessandro Sette</name></author><author><name sortKey="Kalil Filho, Jorge" sort="Kalil Filho, Jorge" uniqKey="Kalil Filho J" first="Jorge" last="Kalil-Filho">Jorge Kalil-Filho</name></author><author><name sortKey="Watkins, David I" sort="Watkins, David I" uniqKey="Watkins D" first="David I" last="Watkins">David I. Watkins</name></author><author><name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G" last="Kallas">Esper G. Kallas</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20625436</idno><idno type="pmid">20625436</idno><idno type="doi">10.1371/journal.pone.0011436</idno><idno type="wicri:Area/PubMed/Corpus">001F46</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F46</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.</title><author><name sortKey="Tarosso, Leandro F" sort="Tarosso, Leandro F" uniqKey="Tarosso L" first="Leandro F" last="Tarosso">Leandro F. Tarosso</name><affiliation><nlm:affiliation>Clinical Immunology and Allergy Division, University of Sao Paulo, Sao Paulo, Brazil.</nlm:affiliation></affiliation></author><author><name sortKey="Sauer, Mariana M" sort="Sauer, Mariana M" uniqKey="Sauer M" first="Mariana M" last="Sauer">Mariana M. Sauer</name></author><author><name sortKey="Sanabani, Sabri" sort="Sanabani, Sabri" uniqKey="Sanabani S" first="Sabri" last="Sanabani">Sabri Sanabani</name></author><author><name sortKey="Giret, Maria Teresa" sort="Giret, Maria Teresa" uniqKey="Giret M" first="Maria Teresa" last="Giret">Maria Teresa Giret</name></author><author><name sortKey="Tomiyama, Helena I" sort="Tomiyama, Helena I" uniqKey="Tomiyama H" first="Helena I" last="Tomiyama">Helena I. Tomiyama</name></author><author><name sortKey="Sidney, John" sort="Sidney, John" uniqKey="Sidney J" first="John" last="Sidney">John Sidney</name></author><author><name sortKey="Piaskowski, Shari M" sort="Piaskowski, Shari M" uniqKey="Piaskowski S" first="Shari M" last="Piaskowski">Shari M. Piaskowski</name></author><author><name sortKey="Diaz, Ricardo S" sort="Diaz, Ricardo S" uniqKey="Diaz R" first="Ricardo S" last="Diaz">Ricardo S. Diaz</name></author><author><name sortKey="Sabino, Ester C" sort="Sabino, Ester C" uniqKey="Sabino E" first="Ester C" last="Sabino">Ester C. Sabino</name></author><author><name sortKey="Sette, Alessandro" sort="Sette, Alessandro" uniqKey="Sette A" first="Alessandro" last="Sette">Alessandro Sette</name></author><author><name sortKey="Kalil Filho, Jorge" sort="Kalil Filho, Jorge" uniqKey="Kalil Filho J" first="Jorge" last="Kalil-Filho">Jorge Kalil-Filho</name></author><author><name sortKey="Watkins, David I" sort="Watkins, David I" uniqKey="Watkins D" first="David I" last="Watkins">David I. Watkins</name></author><author><name sortKey="Kallas, Esper G" sort="Kallas, Esper G" uniqKey="Kallas E" first="Esper G" last="Kallas">Esper G. Kallas</name></author></analytic><series><title level="j">PloS one</title><idno type="eISSN">1932-6203</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term><term>Cohort Studies</term><term>Epitopes (genetics)</term><term>Epitopes (immunology)</term><term>Genetic Variation (genetics)</term><term>Genome, Viral (genetics)</term><term>HIV Infections (immunology)</term><term>HIV Infections (virology)</term><term>HIV-1 (classification)</term><term>HIV-1 (genetics)</term><term>HIV-1 (immunology)</term><term>HLA-B Antigens (genetics)</term><term>Immunity, Cellular (genetics)</term><term>Immunity, Cellular (immunology)</term><term>Likelihood Functions</term><term>Phylogeny</term><term>Polymerase Chain Reaction</term><term>nef Gene Products, Human Immunodeficiency Virus (immunology)</term><term>vif Gene Products, Human Immunodeficiency Virus (immunology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Epitopes</term><term>HLA-B Antigens</term></keywords><keywords scheme="MESH" type="chemical" qualifier="immunology" xml:lang="en"><term>Epitopes</term><term>nef Gene Products, Human Immunodeficiency Virus</term><term>vif Gene Products, Human Immunodeficiency Virus</term></keywords><keywords scheme="MESH" qualifier="classification" xml:lang="en"><term>HIV-1</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Genetic Variation</term><term>Genome, Viral</term><term>HIV-1</term><term>Immunity, Cellular</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>HIV Infections</term><term>HIV-1</term><term>Immunity, Cellular</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>HIV Infections</term></keywords><keywords scheme="MESH" xml:lang="en"><term>CD4-Positive T-Lymphocytes</term><term>Cohort Studies</term><term>Likelihood Functions</term><term>Phylogeny</term><term>Polymerase Chain Reaction</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20625436</PMID><DateCompleted><Year>2010</Year><Month>10</Month><Day>28</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>5</Volume><Issue>7</Issue><PubDate><Year>2010</Year><Month>Jul</Month><Day>02</Day></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS ONE</ISOAbbreviation></Journal><ArticleTitle>Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.</ArticleTitle><Pagination><MedlinePgn>e11436</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0011436</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">HIV-1-infected individuals who spontaneously control viral replication represent an example of successful containment of the AIDS virus. Understanding the anti-viral immune responses in these individuals may help in vaccine design. However, immune responses against HIV-1 are normally analyzed using HIV-1 consensus B 15-mers that overlap by 11 amino acids. Unfortunately, this method may underestimate the real breadth of the cellular immune responses against the autologous sequence of the infecting virus.</AbstractText><AbstractText Label="METHODOLOGY AND PRINCIPAL FINDINGS" NlmCategory="RESULTS">Here we compared cellular immune responses against nef and vif-encoded consensus B 15-mer peptides to responses against HLA class I-predicted minimal optimal epitopes from consensus B and autologous sequences in six patients who have controlled HIV-1 replication. Interestingly, our analysis revealed that three of our patients had broader cellular immune responses against HLA class I-predicted minimal optimal epitopes from either autologous viruses or from the HIV-1 consensus B sequence, when compared to responses against the 15-mer HIV-1 type B consensus peptides.</AbstractText><AbstractText Label="CONCLUSION AND SIGNIFICANCE" NlmCategory="CONCLUSIONS">This suggests that the cellular immune responses against HIV-1 in controller patients may be broader than we had previously anticipated.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tarosso</LastName><ForeName>Leandro F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Clinical Immunology and Allergy Division, University of Sao Paulo, Sao Paulo, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sauer</LastName><ForeName>Mariana M</ForeName><Initials>MM</Initials></Author><Author ValidYN="Y"><LastName>Sanabani</LastName><ForeName>Sabri</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Giret</LastName><ForeName>Maria Teresa</ForeName><Initials>MT</Initials></Author><Author ValidYN="Y"><LastName>Tomiyama</LastName><ForeName>Helena I</ForeName><Initials>HI</Initials></Author><Author ValidYN="Y"><LastName>Sidney</LastName><ForeName>John</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Piaskowski</LastName><ForeName>Shari M</ForeName><Initials>SM</Initials></Author><Author ValidYN="Y"><LastName>Diaz</LastName><ForeName>Ricardo S</ForeName><Initials>RS</Initials></Author><Author ValidYN="Y"><LastName>Sabino</LastName><ForeName>Ester C</ForeName><Initials>EC</Initials></Author><Author ValidYN="Y"><LastName>Sette</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Kalil-Filho</LastName><ForeName>Jorge</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Watkins</LastName><ForeName>David I</ForeName><Initials>DI</Initials></Author><Author ValidYN="Y"><LastName>Kallas</LastName><ForeName>Esper G</ForeName><Initials>EG</Initials></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R24 RR015371</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 AI073230-01</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2010</Year><Month>07</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015235">HLA-B Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C103707">HLA-B57 antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054311">nef Gene Products, Human Immunodeficiency Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C514837">nef protein, Human immunodeficiency virus 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D054320">vif Gene Products, Human Immunodeficiency Virus</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C514847">vif protein, Human immunodeficiency virus 1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>PLoS One. 2013;8(9). doi:10.1371/annotation/3cf88893-7718-4aaa-b518-cf8ed592685e</RefSource></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D015496" MajorTopicYN="N">CD4-Positive T-Lymphocytes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016679" MajorTopicYN="N">Genome, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015658" MajorTopicYN="N">HIV Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015497" MajorTopicYN="N">HIV-1</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015235" MajorTopicYN="N">HLA-B Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007111" MajorTopicYN="N">Immunity, Cellular</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016013" MajorTopicYN="N">Likelihood Functions</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054311" MajorTopicYN="N">nef Gene Products, Human Immunodeficiency Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D054320" MajorTopicYN="N">vif Gene Products, Human Immunodeficiency Virus</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2009</Year><Month>12</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2010</Year><Month>05</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2010</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2010</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2010</Year><Month>10</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20625436</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0011436</ArticleId><ArticleId IdType="pmc">PMC2896403</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Top HIV Med. 2007 Aug-Sep;15(4):134-6</Citation><ArticleIdList><ArticleId IdType="pubmed">17720999</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2007 Apr 17;104(16):6776-81</Citation><ArticleIdList><ArticleId IdType="pubmed">17428922</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 May;74(9):4361-76</Citation><ArticleIdList><ArticleId IdType="pubmed">10756051</ArticleId></ArticleIdList></Reference><Reference><Citation>Eur J Immunol. 2000 Jun;30(6):1676-82</Citation><ArticleIdList><ArticleId IdType="pubmed">10898504</ArticleId></ArticleIdList></Reference><Reference><Citation>Virology. 2000 Oct 10;276(1):169-80</Citation><ArticleIdList><ArticleId IdType="pubmed">11022005</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2000 Nov;74(22):10581-8</Citation><ArticleIdList><ArticleId IdType="pubmed">11044102</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2001 Dec;75(24):11983-91</Citation><ArticleIdList><ArticleId IdType="pubmed">11711588</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2002 Jan 3;415(6867):88-92</Citation><ArticleIdList><ArticleId IdType="pubmed">11780123</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Immunol. 2002 Nov;3(11):1061-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12368910</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol Methods. 2003 Apr 1;275(1-2):19-29</Citation><ArticleIdList><ArticleId IdType="pubmed">12667667</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 2003 May;111(10):1547-54</Citation><ArticleIdList><ArticleId IdType="pubmed">12750404</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2003 Jul;77(13):7330-40</Citation><ArticleIdList><ArticleId IdType="pubmed">12805431</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2004 Feb;78(4):2072-81</Citation><ArticleIdList><ArticleId IdType="pubmed">14747572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2004 May;65(5):523-36</Citation><ArticleIdList><ArticleId IdType="pubmed">15172453</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1992 Nov;66(11):6489-95</Citation><ArticleIdList><ArticleId IdType="pubmed">1357189</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2007 Sep;27(3):406-16</Citation><ArticleIdList><ArticleId IdType="pubmed">17892849</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends Immunol. 2007 Dec;28(12):532-40</Citation><ArticleIdList><ArticleId IdType="pubmed">17981085</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2008 Feb 15;197(4):563-71</Citation><ArticleIdList><ArticleId IdType="pubmed">18275276</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Jun;82(11):5398-407</Citation><ArticleIdList><ArticleId IdType="pubmed">18353945</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 2008 Jul 1;36(Web Server issue):W513-8</Citation><ArticleIdList><ArticleId IdType="pubmed">18515843</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2008 Sep;82(17):8422-30</Citation><ArticleIdList><ArticleId IdType="pubmed">18562530</ArticleId></ArticleIdList></Reference><Reference><Citation>Immunity. 2008 Dec 19;29(6):1009-21</Citation><ArticleIdList><ArticleId IdType="pubmed">19062316</ArticleId></ArticleIdList></Reference><Reference><Citation>Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2709-14</Citation><ArticleIdList><ArticleId IdType="pubmed">10694578</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Jul;68(7):4650-5</Citation><ArticleIdList><ArticleId IdType="pubmed">8207839</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1994 Sep;68(9):6103-10</Citation><ArticleIdList><ArticleId IdType="pubmed">8057491</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1995 Jan 26;332(4):209-16</Citation><ArticleIdList><ArticleId IdType="pubmed">7808486</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1995 Apr;69(4):2557-64</Citation><ArticleIdList><ArticleId IdType="pubmed">7884906</ArticleId></ArticleIdList></Reference><Reference><Citation>J Immunol. 1996 Apr 1;156(7):2616-23</Citation><ArticleIdList><ArticleId IdType="pubmed">8786327</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1996 Aug;70(8):5336-45</Citation><ArticleIdList><ArticleId IdType="pubmed">8764044</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 1997 Nov 21;278(5342):1447-50</Citation><ArticleIdList><ArticleId IdType="pubmed">9367954</ArticleId></ArticleIdList></Reference><Reference><Citation>Nucleic Acids Res. 1997 Dec 15;25(24):4876-82</Citation><ArticleIdList><ArticleId IdType="pubmed">9396791</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1998 May;72(5):3646-57</Citation><ArticleIdList><ArticleId IdType="pubmed">9557645</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 1999 Apr;73(4):2675-81</Citation><ArticleIdList><ArticleId IdType="pubmed">10074113</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 1999 Aug 5;341(6):394-402</Citation><ArticleIdList><ArticleId IdType="pubmed">10432324</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature. 2004 Dec 9;432(7018):769-75</Citation><ArticleIdList><ArticleId IdType="pubmed">15592417</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2005 May 1;191(9):1403-9</Citation><ArticleIdList><ArticleId IdType="pubmed">15809897</ArticleId></ArticleIdList></Reference><Reference><Citation>J Infect Dis. 2005 May 1;191(9):1427-34</Citation><ArticleIdList><ArticleId IdType="pubmed">15809900</ArticleId></ArticleIdList></Reference><Reference><Citation>Braz J Infect Dis. 2004 Dec;8(6):399-406</Citation><ArticleIdList><ArticleId IdType="pubmed">15880230</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Infect Dis. 2005 Oct 1;41(7):1053-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16142675</ArticleId></ArticleIdList></Reference><Reference><Citation>AIDS Res Hum Retroviruses. 2006 Feb;22(2):171-6</Citation><ArticleIdList><ArticleId IdType="pubmed">16478399</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2006 May;80(10):5074-7</Citation><ArticleIdList><ArticleId IdType="pubmed">16641299</ArticleId></ArticleIdList></Reference><Reference><Citation>J Exp Med. 2006 May 15;203(5):1357-69</Citation><ArticleIdList><ArticleId IdType="pubmed">16682496</ArticleId></ArticleIdList></Reference><Reference><Citation>Blood. 2006 Jun 15;107(12):4781-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16467198</ArticleId></ArticleIdList></Reference><Reference><Citation>Syst Biol. 2006 Aug;55(4):539-52</Citation><ArticleIdList><ArticleId IdType="pubmed">16785212</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS Comput Biol. 2006 Jun 9;2(6):e65</Citation><ArticleIdList><ArticleId IdType="pubmed">16789818</ArticleId></ArticleIdList></Reference><Reference><Citation>J Virol. 2007 Apr;81(7):3465-76</Citation><ArticleIdList><ArticleId IdType="pubmed">17251286</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/MersV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F46 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001F46 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= MersV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:20625436
|texte= Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:20625436" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a MersV1
| This area was generated with Dilib version V0.6.33. |  |